742062-20-0

Basic information

• Product Name: 2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-5,7-dihydroxy-3-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)-4H-chromen-4-one
• Synonyms: 2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-5,7-dihydroxy-3-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)-4H-chromen-4-one
• CAS NO: 742062-20-0
• Molecular Weight: 796.738
• Mol File: 742062-20-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-5,7-dihydroxy-3-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)-4H-chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-5,7-dihydroxy-3-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)-4H-chromen-4-one(742062-20-0)
• EPA Substance Registry System: 2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-5,7-dihydroxy-3-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)-4H-chromen-4-one(742062-20-0)

Safety Data

• Hazardous Substances Data: 742062-20-0(Hazardous Substances Data)

Upstream product

• 3068-32-4 1-bromo-2,3,4,6-tetra-O-acetyl-D-galactopyranose 
• 357194-03-7 2-(2,2-diphenylbenzo[1,3]dioxol-5-yl)-3,5,7-trihydroxychromen-4-one 
• 572-09-8 2,3,4,6-tetra-O-acetyl-D-glucopyranosyl bromide 
• 117-39-5 quercetol 
• 3068-32-4 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl-a-D-galactopyranoside 
• 2051-90-3 Dichlorodiphenylmethane 

Downstream Products

• 482-36-0 Hyperoside 
• 1262615-36-0 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-tetraacetylgalactosyl-4H-chromen-4-one 
• 1262615-37-1 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-galactosyl-4H-chromen-4-one 
• 1262615-38-2 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-(3'',4''-O-isopropylidene)galactosyl-4H-chromen-4-one 
• 1262615-39-3 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-ethoxybenzoyl)-3'',4''-O-isopropylidene]galactosyl-4H-chromen-4-one 
• 1262615-40-6 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-propylbenzoyl)-3'',4''-O-isopropylidene]galactosyl-4H-chromen-4-one 
• 1262615-41-7 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-fluorobenzoyl)-3'',4''-O-isopropylidene]galactosyl-4H-chromen- 
• 1262615-42-8 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-methylphenylacetyl)-3'',4''-O-isopropylidene]galactosyl-4H-chromen-4-one 
• 1262615-43-9 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)-3'',4''-O-isopropylidene]galactosyl-4H-chromen-4-one 
• 1262615-52-0 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-ethoxybenzoyl)]glucosyl-4H-chromen-4-one 
• 1262615-53-1 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-propylbenzoyl)]galactosyl-4H-chromen-4-one 
• 1262615-54-2 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-fluorobenzoyl)]galactosyl-4H-chromen-4-one 
• 1262615-55-3 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-methylphenylacetyl)]galactosyl-4H-chromen-4-one 
• 1262615-56-4 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one 

Relevant articles and documents

NOVEL FLAVANONE DERIVATIVE

Provided is a novel antimicrobial agent. More specifically, provided is a novel antimicrobial agent capable of effectively acting on various resistant bacteria such as VSSA, MRSA, VISA, VRE, and VRSA. A novel flavanone derivative having a six-membered monosaccharide derivative, specifically, a glucose derivative or a galactose derivative is capable of effectively acting on the bacteria. More specifically, a compound represented by the general formula (I) is capable of effectively acting on the bacteria. (In the formula: X represents a six-membered monosaccharide derivative; and Y is substituted by a hydroxyl group.)

Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure-activity relationship studies reveal salient pharmacophore features

The 3C-like protease (3CLpro) of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is one of the most promising targets for discovery of drugs against SARS, because of its critical role in the viral life cycle. In this study,